Legal & General Group Plc Buys 201,667 Shares of Sabra Healthcare REIT, Inc. $SBRA

Legal & General Group Plc lifted its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 16.5% in the 4th quarter, Holdings Channel reports. The institutional investor owned 1,427,180 shares of the real estate investment trust’s stock after acquiring an additional 201,667 shares during the period. Legal & General Group Plc’s holdings in Sabra Healthcare REIT were worth $27,031,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Cornerstone Wealth Management LLC lifted its stake in shares of Sabra Healthcare REIT by 256.6% in the third quarter. Cornerstone Wealth Management LLC now owns 39,781 shares of the real estate investment trust’s stock valued at $742,000 after buying an additional 28,625 shares during the period. Bank of Montreal Can lifted its stake in shares of Sabra Healthcare REIT by 8.2% in the third quarter. Bank of Montreal Can now owns 2,787,655 shares of the real estate investment trust’s stock valued at $51,962,000 after buying an additional 211,686 shares during the period. Allianz Asset Management GmbH lifted its stake in shares of Sabra Healthcare REIT by 9.9% in the third quarter. Allianz Asset Management GmbH now owns 902,998 shares of the real estate investment trust’s stock valued at $16,832,000 after buying an additional 81,293 shares during the period. Principal Financial Group Inc. lifted its stake in shares of Sabra Healthcare REIT by 21.6% in the fourth quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock valued at $472,617,000 after buying an additional 4,431,897 shares during the period. Finally, Greenland Capital Management LP bought a new stake in shares of Sabra Healthcare REIT in the third quarter valued at about $4,194,000. Institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Stock Performance

NASDAQ:SBRA opened at $19.89 on Monday. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96. The stock has a market capitalization of $5.02 billion, a P/E ratio of 31.57, a price-to-earnings-growth ratio of 1.49 and a beta of 0.65. The firm has a 50 day moving average of $20.29 and a 200-day moving average of $19.71. Sabra Healthcare REIT, Inc. has a 1 year low of $17.13 and a 1 year high of $21.28.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.16. The business had revenue of $211.74 million during the quarter, compared to analyst estimates of $209.20 million. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. Sabra Healthcare REIT’s revenue for the quarter was up 20.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, sell-side analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.51 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, May 29th. Investors of record on Friday, May 15th were issued a $0.30 dividend. The ex-dividend date of this dividend was Friday, May 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.0%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 190.48%.

Analysts Set New Price Targets

A number of research analysts have commented on SBRA shares. Weiss Ratings cut shares of Sabra Healthcare REIT from a “buy (a-)” rating to a “buy (b+)” rating in a research note on Friday, May 1st. Truist Financial raised their price target on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “hold” rating in a research note on Friday, March 13th. Wall Street Zen upgraded shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Monday, May 18th. UBS Group raised their price target on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 13th. Finally, Citizens Jmp lifted their target price on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a research note on Wednesday, February 18th. Five investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Sabra Healthcare REIT has a consensus rating of “Moderate Buy” and a consensus target price of $22.30.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.